Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus Macbeth

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Thorax|November 13, 2012
Surgical resection of lung cancer in England: more operations but no trials to test their effectivenessTom Treasure, Christopher Russell, Dion Morton, et al.
Thorax|June 26, 2012
Surgical resection of lung cancer England: more operations but no trials to test their effectivenessTom Treasure, Christopher Russell, Dion Morton, et al.
BMJ (Clinical Research Ed.)|July 31, 2015
Melanoma: summary of NICE guidanceFergus Macbeth, Julia Newton-Bishop, Susan O'Connell, et al.
The Cochrane Database of Systematic Reviews|June 18, 2010
Concurrent chemoradiotherapy in non-small cell lung cancerNoelle O'Rourke, Marta Roqué I Figuls, Nuria Farré Bernadó, et al.
The Cochrane Database of Systematic Reviews|January 15, 2015
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancerRosemary Stevens, Fergus Macbeth, Elizabeth Toy, et al.
Lancet (London, England)|January 10, 2021
The fallacy of large survival gains from lung metastasectomy in colorectal cancerTom Treasure, Fergus Macbeth, Vern Farewell, et al.
Plos One|February 4, 2010
The average body surface area of adult cancer patients in the UK: a multicentre retrospective studyJoseph J Sacco, Joanne Botten, Fergus Macbeth, et al.
British Journal of Cancer|September 16, 2015
Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomyGiuseppe Cardillo, Sahar Mokhles, Norman Williams, et al.
The Lancet. Oncology|April 4, 2009
10 years of NICE: still growing and still controversialPeter Littlejohns, Sarah Garner, Nick Doyle, et al.
BMJ (Clinical Research Ed.)|November 9, 2023
Removal or ablation of asymptomatic lung metastases should be reconsideredFergus Macbeth, Lesley Fallowfield, Elizabeth Treasure, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Thorax|November 13, 2012
Surgical resection of lung cancer in England: more operations but no trials to test their effectivenessTom Treasure, Christopher Russell, Dion Morton, et al.
Thorax|June 26, 2012
Surgical resection of lung cancer England: more operations but no trials to test their effectivenessTom Treasure, Christopher Russell, Dion Morton, et al.
BMJ (Clinical Research Ed.)|July 31, 2015
Melanoma: summary of NICE guidanceFergus Macbeth, Julia Newton-Bishop, Susan O'Connell, et al.
The Cochrane Database of Systematic Reviews|June 18, 2010
Concurrent chemoradiotherapy in non-small cell lung cancerNoelle O'Rourke, Marta Roqué I Figuls, Nuria Farré Bernadó, et al.
The Cochrane Database of Systematic Reviews|January 15, 2015
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancerRosemary Stevens, Fergus Macbeth, Elizabeth Toy, et al.
Lancet (London, England)|January 10, 2021
The fallacy of large survival gains from lung metastasectomy in colorectal cancerTom Treasure, Fergus Macbeth, Vern Farewell, et al.
Plos One|February 4, 2010
The average body surface area of adult cancer patients in the UK: a multicentre retrospective studyJoseph J Sacco, Joanne Botten, Fergus Macbeth, et al.
British Journal of Cancer|September 16, 2015
Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomyGiuseppe Cardillo, Sahar Mokhles, Norman Williams, et al.
The Lancet. Oncology|April 4, 2009
10 years of NICE: still growing and still controversialPeter Littlejohns, Sarah Garner, Nick Doyle, et al.
BMJ (Clinical Research Ed.)|November 9, 2023
Removal or ablation of asymptomatic lung metastases should be reconsideredFergus Macbeth, Lesley Fallowfield, Elizabeth Treasure, et al.
Pageof 12